Will Ilumya Kill Valeant's Psoriasis Dreams?

Sun Pharma's Ilumya received FDA approval to treat moderate-to-severe plaque psoriasis.

If it markets Ilumya on par with VRX's Siliq it could compensate for its late entrance to the psoriasis market.

It could also remove Siliq's price advantage and stymie its growth.